Hhlr Advisors LTD. Sells 99,596 Shares of Danaher Co. (NYSE:DHR)

Hhlr Advisors LTD. reduced its position in shares of Danaher Co. (NYSE:DHR) by 91.6% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 9,104 shares of the conglomerate’s stock after selling 99,596 shares during the quarter. Hhlr Advisors LTD.’s holdings in Danaher were worth $2,531,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Fort Pitt Capital Group LLC grew its stake in shares of Danaher by 3.2% during the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after purchasing an additional 7,421 shares during the period. Good Life Advisors LLC purchased a new position in shares of Danaher during the 3rd quarter valued at about $217,000. Oak Thistle LLC purchased a new position in shares of Danaher during the 2nd quarter valued at about $363,000. Harvest Portfolios Group Inc. lifted its position in shares of Danaher by 1.2% during the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after buying an additional 2,465 shares in the last quarter. Finally, Diversified Trust Co lifted its position in shares of Danaher by 75.4% during the 2nd quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate’s stock valued at $1,090,000 after buying an additional 1,874 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

DHR has been the topic of a number of analyst reports. StockNews.com raised Danaher from a “hold” rating to a “buy” rating in a research report on Wednesday. Evercore ISI lifted their price objective on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Stephens reaffirmed an “overweight” rating and set a $315.00 price objective on shares of Danaher in a research report on Wednesday, October 23rd. KeyCorp boosted their price target on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Finally, UBS Group lowered their price target on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $287.16.

Danaher Trading Up 0.4 %

Shares of DHR stock opened at $239.84 on Friday. The company has a market cap of $173.23 billion, a PE ratio of 45.77, a price-to-earnings-growth ratio of 4.39 and a beta of 0.85. Danaher Co. has a 1 year low of $215.68 and a 1 year high of $281.70. The stock’s 50 day simple moving average is $254.59 and its two-hundred day simple moving average is $259.44. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same period in the previous year, the firm earned $2.02 earnings per share. Danaher’s quarterly revenue was up 3.1% compared to the same quarter last year. Research analysts predict that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were paid a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.45%. The ex-dividend date was Friday, September 27th. Danaher’s payout ratio is currently 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.